日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial

单克隆抗体 Sotrovimab 肌注治疗早期轻度至中度 COVID-19 患者的安全性、耐受性、药代动力学和病毒药效学：一项随机临床试验

期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-025-00529-2
Gupta, Anil; Perez-Rodríguez, Maria Teresa; Gonzalez-Rojas, Yaneicy; Ramgopal, Moti; Free, Almena; Han, Jennifer; Moore, Jennifer; Givens, Naomi; Yates, Phillip J; Walker, Jill T; Connolly, Mary Beth; Schnell, Gretja; Imber, Varsha; Anselm, Rabia; Winograd, Lindsay; Segal, Scott; Harrison, Stephen; Skingsley, Andrew; Aldinger, Melissa; Peppercorn, Amanda; Moya, Jaynier
单克隆抗体
微生物学
发表日期：2025
文献求助 收藏

A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA)

随机、安慰剂对照试验，评估 VIR-2482 在健康成人中预防甲型流感疾病的安全性和有效性（PENINSULA）

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae368
Tan, Susanna K; Cebrik, Deborah; Plotnik, David; Agostini, Maria L; Boundy, Keith; Hebner, Christy M; Yeh, Wendy W; Pang, Phillip S; Moya, Jaynier; Fogarty, Charles; Darani, Manuchehr; Hayden, Frederick G
微生物学
流感
发表日期：2024
文献求助 收藏

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

肌注与静脉注射SARS-CoV-2中和抗体Sotrovimab治疗COVID-19的疗效比较（COMET-TAIL）：一项随机非劣效性临床试验

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad354
Shapiro, Adrienne E; Sarkis, Elias; Acloque, Jude; Free, Almena; Gonzalez-Rojas, Yaneicy; Hussain, Rubaba; Juarez, Erick; Moya, Jaynier; Parikh, Naval; Inman, David; Cebrik, Deborah; Nader, Ahmed; Noormohamed, Nadia; Wang, Qianwen; Skingsley, Andrew; Austin, Daren; Peppercorn, Amanda; Agostini, Maria L; Parra, Sergio; Chow, Sophia; Mogalian, Erik; Pang, Phillip S; Hong, David K; Sager, Jennifer E; Yeh, Wendy W; Alexander, Elizabeth L; Gaffney, Leah A; Kohli, Anita
SARS-CoV-2
MET
发表日期：2023
文献求助 收藏

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial

高剂量静脉注射索托维单抗治疗轻度至中度 COVID-19 的安全性、病毒学、药代动力学和临床经验：一项开放标签临床试验

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad344
Moya, Jaynier; Temech, Marisol; Parra, Sergio; Juarez, Erick; Hernandez-Loy, Reinaldo; Gutierrez, Juan C Moises; Diaz, Jorge; Hussain, Rubaba; Segal, Scott; Xu, Claire; Skingsley, Andrew; Schnell, Gretja; El-Zailik, Asma; Sager, Jennifer E; Aldinger, Melissa; Alexander, Elizabeth L; Acloque, Gerard
微生物学
发表日期：2023
文献求助 收藏

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

Sotrovib 对轻中度 COVID-19 高危患者住院或死亡的影响：一项随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2022.2832
Gupta, Anil; Gonzalez-Rojas, Yaneicy; Juarez, Erick; Crespo Casal, Manuel; Moya, Jaynier; Rodrigues Falci, Diego; Sarkis, Elias; Solis, Joel; Zheng, Hanzhe; Scott, Nicola; Cathcart, Andrea L; Parra, Sergio; Sager, Jennifer E; Austin, Daren; Peppercorn, Amanda; Alexander, Elizabeth; Yeh, Wendy W; Brinson, Cynthia; Aldinger, Melissa; Shapiro, Adrienne E
发表日期：2022
文献求助 收藏